IGM Biosciences, Inc. Proceeds from Contributed Capital
IGM Biosciences, Inc. reported Proceeds from Contributed Capital of $2.55 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2022-03-29
- IGM Biosciences, Inc. proceeds from contributed capital for fiscal 2019 was $2.55M.
| Period end | Proceeds from Contributed Capital 12 month |
|---|---|
| 2019-12-31 | $2.55M 10-K · filed 2022-03-29 |